AbbVie (ABBV) Change in Inventory (2012 - 2026)

AbbVie (ABBV) has reported Change in Inventory for 15 consecutive years, with $143.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Inventory rose 155.36% year-over-year to $143.0 million in Q2 2026; TTM through Jun 2026 was $350.0 million, a 13.15% decrease from a year earlier, with the FY2025 full-year figure at $234.0 million, down 26.65% from the prior year.
• Change in Inventory was $143.0 million for Q2 2026 at AbbVie, down from $184.0 million in the prior quarter.
• Over five years, Change in Inventory peaked at $385.0 million in Q1 2022 and troughed at -$96.0 million in Q4 2023.
• A 5-year average of $110.2 million and a median of $94.5 million in 2022 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory tumbled 156.47% in 2023 and jumped 233.33% in 2024, its largest moves.
• Over 5 years, Change in Inventory stood at $170.0 million in 2022, then slumped by 156.47% to -$96.0 million in 2023, then jumped by 233.33% to $128.0 million in 2024, then sank by 80.47% to $25.0 million in 2025, then soared by 472.0% to $143.0 million in 2026.
• The last three Change in Inventory figures came in at $143.0 million (Q2 2026), $184.0 million (Q1 2026), and $25.0 million (Q4 2025), per Business Quant data.